• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成骨细胞在破骨细胞分化中的新作用。

New roles of osteoblasts involved in osteoclast differentiation.

作者信息

Yamashita Teruhito, Takahashi Naoyuki, Udagawa Nobuyuki

机构信息

Teruhito Yamashita, Naoyuki Takahashi, Institute for Oral Science, Matsumoto Dental University, 1780 Gobara, Hirooka, Shiojiri, Nagano 399-0781, Japan.

出版信息

World J Orthop. 2012 Nov 18;3(11):175-81. doi: 10.5312/wjo.v3.i11.175.

DOI:10.5312/wjo.v3.i11.175
PMID:23330072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3547111/
Abstract

Bone-resorbing osteoclasts are formed from a monocyte/macrophage lineage under the strict control of bone-forming osteoblasts. So far, macrophage colony-stimulating factor (M-CSF), receptor activator of nuclear factor-κB ligand (RANKL), and osteoprotegerin (OPG) produced by osteoblasts play major roles in the regulation of osteoclast differentiation. Recent studies have shown that osteoblasts regulate osteoclastogenesis through several mechanisms independent of M-CSF, RANKL, and OPG production. Identification of osteoclast-committed precursors in vivo demonstrated that osteoblasts are involved in the distribution of osteoclast precursors in bone. Interleukin 34 (IL-34), a novel ligand for c-Fms, plays a pivotal role in maintaining the splenic reservoir of osteoclast-committed precursors in M-CSF deficient mice. IL-34 is also able to act as a substitute for osteoblast-producing M-CSF in osteoclastogenesis. Wnt5a, produced by osteoblasts, enhances osteoclast differentiation by upregulating RANK expression through activation of the non-canonical Wnt pathway. Semaphorin 3A produced by osteoblasts inhibits RANKL-induced osteoclast differentiation through the suppression of immunoreceptor tyrosine-based activation motif signals. Thus, recent findings show that osteoclast differentiation is tightly regulated by osteoblasts through several different mechanisms. These newly identified molecules are expected to be promising targets of therapeutic agents in bone-related diseases.

摘要

骨吸收破骨细胞由单核细胞/巨噬细胞谱系在成骨细胞的严格控制下形成。到目前为止,成骨细胞产生的巨噬细胞集落刺激因子(M-CSF)、核因子κB受体活化因子配体(RANKL)和骨保护素(OPG)在破骨细胞分化的调节中起主要作用。最近的研究表明,成骨细胞通过几种独立于M-CSF、RANKL和OPG产生的机制调节破骨细胞生成。体内破骨细胞定向前体的鉴定表明,成骨细胞参与破骨细胞前体在骨中的分布。白细胞介素34(IL-34)是c-Fms的一种新型配体,在维持M-CSF缺陷小鼠破骨细胞定向前体的脾脏储存库中起关键作用。IL-34在破骨细胞生成中也能够替代成骨细胞产生的M-CSF。成骨细胞产生的Wnt5a通过激活非经典Wnt途径上调RANK表达来增强破骨细胞分化。成骨细胞产生的信号素3A通过抑制基于免疫受体酪氨酸的激活基序信号来抑制RANKL诱导的破骨细胞分化。因此,最近的研究结果表明,破骨细胞分化受成骨细胞通过几种不同机制的严格调控。这些新发现的分子有望成为骨相关疾病治疗药物的有前景的靶点。

相似文献

1
New roles of osteoblasts involved in osteoclast differentiation.成骨细胞在破骨细胞分化中的新作用。
World J Orthop. 2012 Nov 18;3(11):175-81. doi: 10.5312/wjo.v3.i11.175.
2
Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.成骨细胞/基质细胞通过表达破骨细胞分化因子/核因子κB受体活化因子配体(RANKL)而非巨噬细胞集落刺激因子来刺激破骨细胞活化:核因子κB受体活化因子配体。
Bone. 1999 Nov;25(5):517-23. doi: 10.1016/s8756-3282(99)00210-0.
3
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.衰老会增加基质/成骨细胞诱导的破骨细胞生成,并改变小鼠体内破骨细胞前体细胞库。
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
4
Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals.核因子κB 受体活化因子配体和 Wnt 信号对破骨细胞生成的调控机制。
Front Biosci (Landmark Ed). 2011 Jan 1;16(1):21-30. doi: 10.2741/3673.
5
Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.成纤维细胞生长因子2对破骨细胞分化的调节作用:刺激成骨细胞中核因子κB受体激活剂配体/破骨细胞分化因子的表达,并抑制破骨细胞前体细胞中巨噬细胞集落刺激因子的功能。
J Bone Miner Res. 2001 Nov;16(11):2074-81. doi: 10.1359/jbmr.2001.16.11.2074.
6
Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.白细胞介素-6与前列腺素E2信号系统之间的相互作用,通过影响骨保护素/核因子-κB受体激活因子配体(RANKL)/核因子-κB受体激活因子(RANK)系统,导致破骨细胞生成增强。
Endocrinology. 2005 Apr;146(4):1991-8. doi: 10.1210/en.2004-1167. Epub 2004 Dec 23.
7
Osteoclast differentiation by RANKL and OPG signaling pathways.破骨细胞通过 RANKL 和 OPG 信号通路的分化。
J Bone Miner Metab. 2021 Jan;39(1):19-26. doi: 10.1007/s00774-020-01162-6. Epub 2020 Oct 20.
8
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.成纤维细胞样基质细胞表达核因子κB受体活化因子配体并支持破骨细胞分化。
J Bone Miner Res. 2000 Aug;15(8):1459-66. doi: 10.1359/jbmr.2000.15.8.1459.
9
Action of RANKL and OPG for osteoclastogenesis.RANKL和OPG在破骨细胞生成中的作用。
Crit Rev Eukaryot Gene Expr. 2009;19(1):61-72. doi: 10.1615/critreveukargeneexpr.v19.i1.30.
10
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.成骨细胞产生的骨保护素是破骨细胞发育和功能的重要调节因子。
Endocrinology. 2000 Sep;141(9):3478-84. doi: 10.1210/endo.141.9.7634.

引用本文的文献

1
A Mechanically Stimulated Co-culture in 3-Dimensional Composite Scaffolds Promotes Osteogenic and Anti-osteoclastogenic Activity and M2 Macrophage Polarization.三维复合支架中的机械刺激共培养促进成骨和抗破骨细胞生成活性以及M2巨噬细胞极化。
Biomater Res. 2025 Feb 5;29:0135. doi: 10.34133/bmr.0135. eCollection 2025.
2
Clofazimine inhibits small-cell lung cancer progression by modulating the kynurenine/aryl hydrocarbon receptor axis.氯法齐明通过调节犬尿氨酸/芳烃受体轴抑制小细胞肺癌进展。
Int J Biol Macromol. 2024 Dec;282(Pt 3):136921. doi: 10.1016/j.ijbiomac.2024.136921. Epub 2024 Oct 28.
3
IFN-β mediates the anti-osteoclastic effect of bisphosphonates and dexamethasone.干扰素-β介导双膦酸盐和地塞米松的抗破骨细胞作用。
Front Pharmacol. 2022 Oct 14;13:1002550. doi: 10.3389/fphar.2022.1002550. eCollection 2022.
4
A quantitative analysis of macrophage-colony-stimulating factor in peri-miniscrew implant crevicular fluid before and after orthodontic loading.正畸加载前后微型螺钉种植体龈沟液中巨噬细胞集落刺激因子的定量分析。
Angle Orthod. 2023 Mar 1;93(2):222-227. doi: 10.2319/062322-445.1.
5
Evaluation of regeneration after the application of 2 types of deproteinized bovine bone mineral to alveolar bone defects in adult dogs.两种脱蛋白牛骨矿物质应用于成年犬牙槽骨缺损后再生情况的评估
J Periodontal Implant Sci. 2022 Oct;52(5):370-382. doi: 10.5051/jpis.2106080304.
6
Exposure to Inflammatory Mediators Affects the Differentiation of Mesenchymal Progenitors.暴露于炎症介质会影响间充质祖细胞的分化。
Front Bioeng Biotechnol. 2022 Jun 22;10:908507. doi: 10.3389/fbioe.2022.908507. eCollection 2022.
7
Differentiation of Cells Isolated from Human Femoral Heads into Functional Osteoclasts.从人股骨头分离的细胞向功能性破骨细胞的分化。
J Dev Biol. 2022 Jan 18;10(1):6. doi: 10.3390/jdb10010006.
8
The Effects of Crocin on Bone and Cartilage Diseases.西红花苷对骨骼和软骨疾病的影响。
Front Pharmacol. 2022 Jan 19;12:830331. doi: 10.3389/fphar.2021.830331. eCollection 2021.
9
Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.通过 Hsp90ab1/肌球蛋白结合蛋白介导的 TGFβ/FN1/CD44 信号抑制,利用成骨细胞蛋白质组抑制乳腺癌相关性骨丢失。
Theranostics. 2022 Jan 1;12(2):929-943. doi: 10.7150/thno.66148. eCollection 2022.
10
Analyses of Bone Regeneration Capacity of Freeze-Dried Bovine Bone and Combined Deproteinized-Demineralized Bovine Bone Particles in Mandibular Defects: The Potential Application of Biological Forms of Bovine-Bone Filler.冻干牛骨与复合脱蛋白-脱矿质牛骨颗粒在下颌骨缺损中的骨再生能力分析:牛骨填充生物形态的潜在应用
Eur J Dent. 2022 May;16(2):403-413. doi: 10.1055/s-0041-1736291. Epub 2021 Nov 23.

本文引用的文献

1
Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice.脾脏通过在骨质硬化症 op/op 小鼠中诱导维生素 D 表达的 IL-34 来充当破骨细胞前体的储库。
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):10006-11. doi: 10.1073/pnas.1207361109. Epub 2012 Jun 5.
2
Osteoprotection by semaphorin 3A.信号蛋白 3A 的护骨作用。
Nature. 2012 May 3;485(7396):69-74. doi: 10.1038/nature11000.
3
Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.Fos 在骨微环境中破骨细胞前体的 RANK 表达上调中发挥重要作用。
J Cell Sci. 2012 Jun 15;125(Pt 12):2910-7. doi: 10.1242/jcs.099986. Epub 2012 Mar 27.
4
Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.成骨细胞系细胞与破骨细胞前体细胞之间的 Wnt5a-Ror2 信号增强了破骨细胞生成。
Nat Med. 2012 Feb 19;18(3):405-12. doi: 10.1038/nm.2653.
5
Lineage-committed osteoclast precursors circulate in blood and settle down into bone.定向祖细胞型破骨细胞前体在血液中循环,并定居在骨骼中。
J Bone Miner Res. 2011 Dec;26(12):2978-90. doi: 10.1002/jbmr.490.
6
OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice.OSCAR 是一种胶原蛋白受体,可在 DAP12 缺陷的人类和小鼠中增强破骨细胞生成。
J Clin Invest. 2011 Sep;121(9):3505-16. doi: 10.1172/JCI45913. Epub 2011 Aug 15.
7
The critical role of IL-34 in osteoclastogenesis.IL-34 在破骨细胞生成中的关键作用。
PLoS One. 2011 Apr 8;6(4):e18689. doi: 10.1371/journal.pone.0018689.
8
Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.地舒单抗对比唑来膦酸治疗晚期乳腺癌骨转移患者的随机、双盲研究。
J Clin Oncol. 2010 Dec 10;28(35):5132-9. doi: 10.1200/JCO.2010.29.7101. Epub 2010 Nov 8.
9
IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation.白细胞介素-34(IL-34)和巨噬细胞集落刺激因子(M-CSF)共享 Fms 受体,但在生物学活性和信号激活方面并不完全相同。
Cell Death Differ. 2010 Dec;17(12):1917-27. doi: 10.1038/cdd.2010.60. Epub 2010 May 21.
10
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.地诺单抗预防绝经后骨质疏松症女性骨折
N Engl J Med. 2009 Aug 20;361(8):756-65. doi: 10.1056/NEJMoa0809493. Epub 2009 Aug 11.